pentobarbital will decrease the level or outcome of buprenorphine, extended-acting injection by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Patients who transfer to buprenorphine extensive-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers needs to be monitore